【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Liver Fibrosis Overview 7
Therapeutics Development 8
Pipeline Products for Liver Fibrosis – Overview 8
Pipeline Products for Liver Fibrosis – Comparative Analysis 9
Liver Fibrosis – Therapeutics under Development by Companies 10
Liver Fibrosis – Therapeutics under Investigation by Universities/Institutes 12
Liver Fibrosis – Pipeline Products Glance 13
Clinical Stage Products 13
Early Stage Products 14
Liver Fibrosis – Products under Development by Companies 15
Liver Fibrosis – Products under Investigation by Universities/Institutes 18
Liver Fibrosis – Companies Involved in Therapeutics Development 19
Advinus Therapeutics Ltd. 19
Angion Biomedica Corp. 20
BerGenBio AS 21
BiOrion Technologies B.V. 22
Celgene Corporation 23
Digna Biotech, S.L. 24
FibroGen, Inc. 25
Galectin Therapeutics, Inc. 26
Genfit SA 27
GenKyoTex S.A. 28
Gilead Sciences, Inc. 29
GNI Group Ltd. 30
La Jolla Pharmaceutical Company 31
LG Life Sciences, Ltd. 32
Nitto Denko Corporation 33
Pharmaxis Limited 34
Promedior, Inc. 35
Promethera Biosciences S.A. 36
ProMetic Life Sciences Inc. 37
RXi Pharmaceuticals Corporation 38
TCM Biotech International Corp 39
Vascular Biogenics Ltd. 40
Virobay Inc. 41
Liver Fibrosis – Therapeutics Assessment 42
Assessment by Monotherapy Products 42
Assessment by Target 43
Assessment by Mechanism of Action 46
Assessment by Route of Administration 48
Assessment by Molecule Type 50
Drug Profiles 52
ANG-3281 – Drug Profile 52
ANG-3298 – Drug Profile 53
ANG-4011 – Drug Profile 54
BGB-324 – Drug Profile 55
BOT-162 – Drug Profile 56
BOT-191 – Drug Profile 57
CC-539 – Drug Profile 58
CC-90001 – Drug Profile 59
CIGB-500 – Drug Profile 60
CT-140 – Drug Profile 61
DB-036 – Drug Profile 62
DCBBO-1202 – Drug Profile 63
disitertide – Drug Profile 64
Drugs to Inhibit NADPH Oxidase for Influenza and Liver Fibrosis – Drug Profile 66
F-351 – Drug Profile 67
FG-3019 – Drug Profile 69
GCS-100 – Drug Profile 71
GFT-505 – Drug Profile 73
GKT-137831 – Drug Profile 76
GKT-901 – Drug Profile 77
GM-CT-01 – Drug Profile 78
GM-CT-02 – Drug Profile 81
GR-MD-01 – Drug Profile 82
GR-MD-02 – Drug Profile 83
HepaStem – Drug Profile 85
KW-0 – Drug Profile 87
LC-280126 – Drug Profile 88
LJPC-201 – Drug Profile 90
melittin – Drug Profile 91
ND-L02s0201 – Drug Profile 92
NPLC-0393 – Drug Profile 94
P-17 – Drug Profile 95
PBI-4050 – Drug Profile 97
PRI-724 – Drug Profile 98
PRM-151 – Drug Profile 100
PXS-4728A – Drug Profile 102
PXS-5033A – Drug Profile 103
RXI-209 – Drug Profile 104
simtuzumab – Drug Profile 105
Small Molecule for Liver Fibrosis – Drug Profile 107
Small Molecule to Antagonize GPR91 for Retinal Angiogenesis and Liver Fibrosis – Drug Profile 108
Stem Cell Therapy for Liver Fibrosis and Liver Diseases – Drug Profile 109
Synthetic Peptide to Inhibit RSK for Fibrosis and Oncology – Drug Profile 110
TCM-808FB – Drug Profile 111
TGFTX-4 Program – Drug Profile 112
VB-201 – Drug Profile 113
VBY-376 – Drug Profile 115
VBY-825 – Drug Profile 116
Liver Fibrosis – Recent Pipeline Updates 117
Liver Fibrosis – Dormant Projects 150
Liver Fibrosis – Discontinued Products 151
Liver Fibrosis – Product Development Milestones 152
Featured News & Press Releases 152
Appendix 159
Methodology 159
Coverage 159
Secondary Research 159
Primary Research 159
Expert Panel Validation 159
Contact Us 159
Disclaimer 160
【レポート販売概要】
■ タイトル:肝繊維症(Liver Fibrosis):治療薬開発パイプライン動向(2015年上半期版)■ 英文:Liver Fibrosis - Pipeline Review, H1 2015
■ 発行日:2015年2月28日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6351IDB
■ 調査対象地域:グローバル
- Throat Cancer:グローバル臨床試験レビューH2, 2013Throat Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Throat Cancer Global Clinical Trials Review, H2, 2013" provides data on the Throat Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Throat Cancer . It includes an overview of the trial numbers and their recruitment status as per th …
- 医療用マイクロエレクトロニクスインプラントの世界市場2015-2022According to Stratistics MRC, the Global Microelectronic Medical Implants market is accounted for $23.5 billion in 2015 and is expected to reach $43.9 billion by 2022 growing at a CAGR of 9.2% from 2015 to 2022. The factors such as growing incidence rate in epilepsy, increasing incidence of cardiac disorders and parkinson’s diseases are some of the factors driving the market growth. However, high …
- ソーラー・マイクロ・インバータの世界市場2016-2020About the Solar Microinverter Market Solar microinverters are small devices installed on solar panels that convert the DC output of a photovoltaic (PV) panel into AC. These inverters use maximum power point tracking (MPPT) to get maximum power from the PV array. The function of a microinverter is similar to a central or string inverter. In a string inverter, the PV modules are connected in strings …
- 世界の摩擦製品市場動向(2012-2016)TechNavio’s analysts forecast the Global Friction Products market to reach US$18.78 billion by 2016. One of the key factors contributing to this market growth is increasing demand from the Automotive industry. The Global Friction Products market has also been witnessing increasing demand for customized products. However, the increasing threat of low-cost products from local vendors could pose a ch …
- 拡張期心不全(Diastolic Heart Failure):世界の治験レビュー(2015年上半期版)Diastolic Heart Failure Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Diastolic Heart Failure Global Clinical Trials Review, H1, 2015" provides data on the Diastolic Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diastolic Heart Failure. It includes an overview of the trial numbers …
- 音声分析ソリューションの世界市場:スピーチエンジン、索引、分析・クエリーツール、ダッシュボード、レポートツールMarketsandMarkets forecasts the speech analytics market size to grow from USD 589.2 Million in 2015 to USD 1.60 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 22.0% from 2015 to 2020. Today, the multichannel world consists of voice, email, chat, social channels, and surveys, and each channel has its own importance. It has been observed that voice, phone interaction, is the most common …
- RN Holding:石油・ガスの開発・生産動向及びコスト分析- 2012RN Holding Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary RN Holding Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational data, …
- 不妊治療サービスのオーストラリア・ニュージーランド市場:処置別、サービス別、エンドユーザー別The Australia & New Zealand fertility services market generated $709 million in 2018, and is projected to reach $1,020 million by 2026, growing at a CAGR of 4.6% from 2019 to 2026. Fertility services are treatments that assist in treating infertility in patients. In vitro fertilization (IVF), surrogacy, intrauterine insemination, and others are different forms of infertility services that help sin …
- ミオクローヌス(Myoclonus)治療のグローバル臨床試験動向(2014年H2)Myoclonus Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Myoclonus Global Clinical Trials Review, H2, 2014" provides data on the Myoclonus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonus. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
- Vermilion Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Vermilion Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Vermilion Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- 冷凍空気乾燥機の世界市場分析:製品別(サイクル式、非サイクル式)、用途別(化学、製紙、食品・飲料、医薬品、ヘルスケア)、セグメント予測The global Refrigerated Air Dryer Market is expected to reach USD 1.59 billion by 2022, according to a new report by Grand View Research, Inc. It is primarily accredited to several benefits offered, such as the low operating & maintenance cost as well low initial capital investment. The capability to provide variation, high-energy efficiency, portability, low maintenance cost, and eco-friendly ope …
- 無針ドラッグデリバリーデバイスの世界市場:製品別、地域別Global Needle-Free Drug Delivery Devices Market: About this market Technavio’s needle-free drug delivery devices market analysis considers sales from inhalers, transdermal patches, and jet injectors. Our study also finds the sales of needle-free drug delivery devices in Asia, Europe, North America, and ROW. In 2019, the inhalers segment had a significant market share, and this trend is expected to …
- 世界の3D細胞培養市場:製品別(ハイドロゲル、ハンギングドロップ、バイオリアクター、マイクロフルイディクス、磁気浮上)、用途別(がん、幹細胞、毒性学、組織工学)、エンドユーザー別(医薬品、バイオテクノロジー、化粧品)、地域別“The global 3D cell culture market is projected to grow at a CAGR of 15.7% during the forecast period.” The 3D cell culture market is projected to reach USD 1,846 million by 2024 from USD 892 million in 2019, at a CAGR of 15.7%. The growth in this market is primarily driven by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing inci …
- 世界の量子ドット市場Since their synthesis over 30 years ago, Quantum Dots (QDs) have featured in a range of optoelectronic devices, including light-emitting devices (LEDs), solar cells, photodiodes, thermoelectrics, photoconductors and field-effect transistors, while QD solutions have been used in a number of in vivo and in vitro imaging, sensing and labelling techniques. The global market for quantum dots (QD) has w …
- 光学イメージング技術の世界市場:ハイパースペクトル画像、近赤外線分光法、光音響トモグラフィAbout Optical Imaging Optical imaging is a non-invasive technique and is helpful in diagnosing the body by using the visible light and non- ionization radiation. Non-ionization radiation includes visible, UV, and infrared light, which reduces patient exposure to harmful radiation and generates images by exciting electrons. Optical imaging can be combined with MRI and X-rays to provide the enhanced …